扎那米韦。一种强效且选择性的甲型和乙型流感病毒抑制剂。 - Suppr

Suppr

超能文献

Zanamivir. A potent and selective inhibitor of influenza A and B viruses.

作者信息

Aoki F Y, Hayden F G

机构信息

Department of Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Clin Pharmacokinet. 1999;36 Suppl 1:v-ix.

PMID:10429834

Abstract

摘要

相似文献

Zanamivir. A potent and selective inhibitor of influenza A and B viruses.

Clin Pharmacokinet. 1999;36 Suppl 1:v-ix.

Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.

Bioorg Med Chem Lett. 2004 Mar 22;14(6):1589-92. doi: 10.1016/j.bmcl.2003.09.102.

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.

J Med Chem. 1998 Mar 12;41(6):787-97. doi: 10.1021/jm970374b.

Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.

Virology. 1995 Dec 20;214(2):642-6. doi: 10.1006/viro.1995.0078.

Zanamivir: from drug design to the clinic.

Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1885-93. doi: 10.1098/rstb.2001.1021.

Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.

Antiviral Res. 2005 Oct;68(1):43-8. doi: 10.1016/j.antiviral.2005.07.004.

Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.

Virus Res. 2004 Jul;103(1-2):195-7. doi: 10.1016/j.virusres.2004.02.033.

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.

J Med Chem. 1998 Mar 12;41(6):798-807. doi: 10.1021/jm9703754.

[Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].

Nihon Rinsho. 2003 Nov;61(11):1975-9.

Rational design of potent sialidase-based inhibitors of influenza virus replication.

Nature. 1993 Jun 3;363(6428):418-23. doi: 10.1038/363418a0.

引用本文的文献

Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.

Viruses. 2018 Jan 21;10(1):48. doi: 10.3390/v10010048.

Permeability enhancers dramatically increase zanamivir absolute bioavailability in rats: implications for an orally bioavailable influenza treatment.

PLoS One. 2013 Apr 17;8(4):e61853. doi: 10.1371/journal.pone.0061853. Print 2013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Zanamivir. A potent and selective inhibitor of influenza A and B viruses.

作者信息

Aoki F Y, Hayden F G

机构信息

Department of Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Clin Pharmacokinet. 1999;36 Suppl 1:v-ix.

PMID:10429834

Abstract

摘要